GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lyell Immunopharma LYEL · USD

Health Care · US listing · 🇺🇸 United States

Compare

15.42

+3.77%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Lyell Immunopharma

Our reporting

Past results

Reported against what analysts expected

4 Nov 20266 Aug 20266 May 202612 Mar 202612 Nov 202512 Aug 2025
Earnings per share-1.86-1.92-1.10-7.68-2.13-2.89
Forecast-2.06-1.90-2.78-2.15-2.81-3.80
Revenue$3,000$4,000$2,000$6,000$15,000$8,000
Forecast$4,600$3,625$3,000$15,250$5,000$4,000

Key events

  1. 2 Jun 202520-to-1 reverse split
  2. 17 Jun 2021Listed

Lyell Immunopharma in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.